✦ LIBER ✦

Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin

✍ Scribed by N. Fujita; M. Kaito; M. Kai; R. Sugimoto; H. Tanaka; S. Horiike; M. Konishi; M. Iwasa; S. Watanabe; Y. Adachi

Book ID: 108885874
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 185 KB
Volume: 13
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2005.00718.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of pegylated interferon/ri

Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infection

✍ G. BORRONI; M. ANDREOLETTI; M. A. CASIRAGHI; R. CERIANI; P. GUERZONI; B. OMAZZI; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection

✍ CHAO-HUNG HUNG; CHUAN-MO LEE; SHENG-NAN LU; JING-HOUNG WANG; HUNG-DA TUNG; CHIEN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Therapeutic effects of pegylated interfe

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection

✍ Li-Wei Chen; Rong-Nan Chien; Cho-Li Yen; Jia-Jang Chang; Ching-Jung Liu; Chih-La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Genetic variability of hepatitis C virus

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy

✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w